David Roman
Stock Analyst at Goldman Sachs
(2.80)
# 1,966
Out of 5,042 analysts
56
Total ratings
43.75%
Success rate
0.07%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Neutral | $180 → $202 | $187.30 | +7.85% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $82.45 | +26.14% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $18.47 | +19.11% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $27.22 | +21.23% | 3 | Oct 29, 2025 | |
| COO The Cooper Companies | Initiates: Sell | $64 | $69.91 | -8.45% | 1 | Oct 1, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $14.94 | +7.10% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $88.07 | +16.95% | 1 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $66.00 | -3.03% | 4 | Oct 1, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $20 | $11.72 | +70.65% | 1 | Aug 25, 2025 | |
| CARL Carlsmed | Initiates: Buy | $19 | $12.93 | +46.95% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $24.57 | +18.03% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $104 | $94.58 | +9.96% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $313.01 | +21.40% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $100.56 | +3.42% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $8.63 | +15.87% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $74.95 | +9.41% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $27.38 | -16.00% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $123.62 | +24.58% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $14.00 | +71.43% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $69.04 | +2.84% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $52.63 | +4.50% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $356.24 | +19.86% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $100.72 | -10.64% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $534.28 | -6.42% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $178.71 | +53.32% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $90.70 | -8.49% | 1 | May 30, 2024 |
iRhythm Technologies
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $187.30
Upside: +7.85%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $82.45
Upside: +26.14%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $18.47
Upside: +19.11%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $27.22
Upside: +21.23%
The Cooper Companies
Oct 1, 2025
Initiates: Sell
Price Target: $64
Current: $69.91
Upside: -8.45%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $14.94
Upside: +7.10%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $88.07
Upside: +16.95%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $66.00
Upside: -3.03%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $11.72
Upside: +70.65%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $12.93
Upside: +46.95%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $24.57
Upside: +18.03%
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $94.58
Upside: +9.96%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $313.01
Upside: +21.40%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $100.56
Upside: +3.42%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $8.63
Upside: +15.87%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $74.95
Upside: +9.41%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $27.38
Upside: -16.00%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $123.62
Upside: +24.58%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $14.00
Upside: +71.43%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $69.04
Upside: +2.84%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $52.63
Upside: +4.50%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $356.24
Upside: +19.86%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $100.72
Upside: -10.64%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $534.28
Upside: -6.42%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $178.71
Upside: +53.32%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $90.70
Upside: -8.49%